Doxazosin dropped from ALLHAT study.
Miller
J L
JL
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control; D017292:Doxazosin / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D009316:National Institutes of Health (U.S.); D014481:United States
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D017292:Doxazosin